L 104,
L-104,
lysine clonixinate,
Lysine clonixinate,
Clonixin lysine salt,
55837-30-4,
L-Lysine Clonixinate,
L 104,
UNII-06PW4M190R,
L-104,
2-(2'-Methyl-3'-chloroanilino)lysine nicotinate,
06PW4M190R,
L-Lysine, mono(2-((3-chloro-2-methylphenyl)amino)-3-pyridinecarboxylate),
C19H25ClN4O4,
Dolalgial,
L-Lysine, 2-[(3-chloro-2-methylphenyl)amino]-3-pyridinecarboxylate (1:1),
2-[(3-chloro-2-methylphenyl)amino]pyridine-3-carboxylic acid (2S)-2,6-diaminohexanoic acid,
3-Pyridinecarboxylic acid, 2-((3-chloro-2-methylphenyl)amino)-, compd. with L-lysine (1:1),
Dolagial,
Dorixina,
Clonixil (TN),
AC1MIVTI,
L-clonixin lysine salt,
CHEBI:76201,
DTXSID10204436,
EBD2120,
HMS2098M10,
HMS3715M10,
KS-000010QA,
AKOS015895798,
AC-1606,
CCG-221104,
AN-14775,
BC682531,
Q449,
Lysine Clonixinate (L-Lysine Clonixinate),
LS-184278,
FT-0670895,
D07728,
837L304,
SR-01000872701,
I06-1542,
SR-01000872701-1,
2-[(3-chloro-2-methylphenyl)amino]nicotinic acid--L-lysine (1/1),
L-Lysine 2-[(3-Chloro-2-methylphenyl)amino]-3-pyridinecarboxylate,
(2S)-2,6-diazaniumylhexanoate 2-[(3-chloro-2-methylphenyl)amino]nicotinate,
L-Lysine Mono[2-[(3-chloro-2-methylphenyl)amino]-3-pyridinecarboxylate],
2-(3-chloro-2-methyl-anilino)pyridine-3-carboxylic acid; (2S)-2,6-diaminohexanoic acid,
2-(3-chloro-2-methylanilino)pyridine-3-carboxylic acid; (2S)-2,6-diaminohexanoic acid,
2-(3-chloro-2-methylanilino)pyridine-3-carboxylic acid;(2S)-2,6-diaminohexanoic acid,
Clonix,
Deltar,
Clonixin lysine,
Lysineclonixinate,
Clonixin Lysinate,
C13H11ClN2O2.C6H14N2O2,
CID3080836,
C089163,
C13-H11-Cl-N2-O2.C6-H14-N2-O2,
L-Lisina, 2-[(3-cloro-2-metilfenil) amino]-3-piridinecarboxilato (1:1),
L-Lysine, mono[2-[(3-chloro-2-methylphenyl) amino]-3-pyridinecarboxylate],
l-lysinemono(2-((3-chloro-2-methylphenyl)amino)-3-pyridinecarboxylate),